Jaipur Foot All Set to Launch Its Centre in Columbia ( ands. The International Committee of th...)

Jaipur Foot All Set to Launch Its Centre in Columbia

ands. The International Committee of the Red Cross found the Jaipur Foot to be the hardiest to tackle the tough, mountainous Afghan terrain.

Since then, countless landmine victims in many countries have been fitted with the Jaipur Foot. The limb has also provided relief to 15,000 physically disabled people in foreign countries.

The centre is also known as a "mini India" with people flocking to it for relief from all over the country.

"We receive patients from Gujarat in the west to Assam in the east, and from Srinagar in the north to Kanyakumari in the south," said a BMVSS official.

Page: 1 2
Related medicine news :

1. Jaipur Girl’s Rare Feat: The Youngest To Pass Class 12 At The Age Of 1
2. Victims of Landmine Blasts Walks with the Help of Jaipur Foot
3. Chikungunya Outbreak Feared in Jaipur
4. Flower Therapy New Fad In Jaipur
5. An Exclusive Store for Diabetes Care Opened in Jaipur
6. Jaipur Nurses Five Hospital Plans
7. Huge Ayurveda Library Coming Up in Jaipur
8. Stem Cell Research Lab Coming Up in Jaipur
9. Indonesians to Be Fitted Jaipur-made Artificial Limbs
10. Ashley Judd to Visit Jaipur for HIV Cause
11. Jaipur Foot Takes Off for Lebanon

Post Your Comments:

(Date:11/9/2009)...uld boost self-esteem, researchers say , ...ldren are more likely to have handwriting problems...thout autism, researchers say. , The new study ...udy participants had autism spectrum disorder, but...e for perceptual reasoning on an IQ test. , The...

(Date:11/9/2009)...ned sexual function, study says, , , ...e able to restore sexual function to rabbits with ...e lab and implanting it, a new study reports. ,...hers say the technique could one day be used to tr...ere able to show the tissue was able to integrate ...

(Date:11/9/2009)...ire-FirstCall/ - Hard To Treat Diseases (HTDS.PK) ...is, a US$41 billion international healthcare compa...e partner, Zhejiang Tianyuan Bio-Pharmaceutical Co...nd will begin a five-year, $1 billion China initia...increase its investment in its China R&D facil...

(Date:11/9/2009)... be too late when it comes to preventing or improv...Inc. (Take Off Pounds Sensibly), the nonprofit wei... (Vocus) November 9, 2009 -- Tomorrow may b...g a diabetes condition, according to TOPS Club, In...t-loss support organization., , ,Diabetes is a dis...

(Date:11/9/2009)...ghlights positive influence of sports participatio...nt, IL (Vocus) November 9, 2009 -- As people age f...t research has highlighted the importance of exerc...issues. However, a new study published in the Nove...iplinary Approach reveals that there may be signi...

Breaking Medicine News(10 mins):Health News:Handwriting Skills May Lag in Kids With Autism 2 Health News:Scientists Grow New Penile Tissue in the Lab 2 Health News:Scientists Grow New Penile Tissue in the Lab 3 Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2 Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3 Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4 Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2 Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3 Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2

[0] Handwriting Skills May Lag in Kids With Autism [0] Scientists Grow New Penile Tissue in the Lab [1] Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million [0] Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says [1] High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes

... HMS (Nasdaq: HMSY ) today announced that it had...hborhood Health Providers and Optima Health, a Sen... to its managed care portfolio. HMS will provide t...ge not previously known for its Medicaid members, ...

...Feb. 10 Zeus, Inc. is pleased to introduce its en...ccessible via http://www.zeusinc.com . , , With ... user-friendly resource for comprehensive informat...mation into four categories listed on the site,s h...

... New Epocrates Survey Reveals Patients May M... San Mateo, CA (PRWEB) Feb...to make more difficult economic choices than ever ...ake cutbacks on medications that could be harmful ...

...northern Illinois to use a new, cutting edge diagn...mprove patient care and outcomes. , , WOBURN, Mas...ounced OSF Saint Anthony Medical Center in Rockfor...physicians, pharmacists and nurses improve care an...

...., Feb. 10 Arete Therapeutics Inc. today,announce... AR9281, an orally-,administered soluble epoxide h...treatment of type 2 diabetes. S-EH is an enzyme in...81 Phase II clinical trial program breaks new grou...

... decline in procedure volume rate shows signs of s...ure volume up 48% , , Provides near-term financ...FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV ),...and 12 months ended December 31, 2008. , , Fourt...

HMS Awarded New Contracts for Managed Care Services Zeus Debuts Enhanced Website Doctors Fear Patients Not Filling Prescriptions OSF Saint Anthony Medical Center Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results

(Date:11/9/2009)..., Pa., Nov. 9 ARmark Authenticatio...today an alliance in the development and introduct...ntication technology that incorporates microscopic... coatings of solid oral dosage forms (SODFs) to pr...on exclusive rights to market ARmark,s micro-tags ...

(Date:11/9/2009)... Oregon, November 9 Bend Research ...nce in applying innovative pharmaceutical,technolo...ientific and,technical problems, announced today t...x Pharmaceuticals Incorporated, a global biotechno..., Through this new collaboration, Vertex will ...

(Date:11/9/2009)...ov. 9 PAREXEL Internatio... biopharmaceutical services provider, today announ...lities for early phase clinical development throug... manufactures and distributes electrocardiogram (E...XEL is using Mortara Instrument,s Surveyor Telemet...

Breaking Medicine Technology:ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2 ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3 Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2 Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5 Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results 13493 1 Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results 13493 2 Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 1 Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 2 BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 1 BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 2 BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 3 BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 4

[0] ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance [0] Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration [0] PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument

...al Meeting -, - Conference call to be hosted toda..., Conn., Nov. 3 CuraGen Corporation,(Nasdaq: CRG...ng Phase II,trial of CR011-vcMMAE, an antibody-dru...of patients with unresectable Stage III or Stage I...ator, and Professor and Chairman of,the Department...

...ented at AASLD annual meeting, Pivotal Phase III ...ose,who failed prior treatment, SAN FRANCISCO, No...day reported that a planned interim analysis of a,...gational oral hepatitis C,protease inhibitor, in c...ly increased sustained virologic response (SVR) ra...

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients

...gulation (ECP) is a surgical approach to glaucoma ...lized laser application. The ciliary body (which p...from the anterior or posterior segment, through th...asily and accurately identified utilizing endoscop...

Moore Hyperopic Flap Conformer, 48 Diopter

Medicine Products:

Illuminated Laser Probe, Wide Field, Fully Reusable, Autoclavable Moore Hyperopic Flap Conformer, 48 Diopter Ophth. Laser Endoscope - Autoclavable, Reusable E2 Compact 810nm Laser and Endoscopy System

( ands. The International Committee of th...)Jaipur Foot All Set to Launch Its Centre in Columbia,Health